Table 1.
Human disease | Infectious agent | Mode of transmission | Symptoms | Treatment | Available vaccine | Re-emerging EMR countries |
---|---|---|---|---|---|---|
Poliomyelitisa | Polio virus | Fecal–oral | Asymptomatic, may affect the CNS and cause paralysis | Supportive |
Salk Vaccine—IPV: inactivated polio vaccine Sabin Vaccine—OPV: oral polio vaccine |
Syria, Iraq |
Measlesb | Measles virus | Direct contact with infectious droplet or by airborne spread | Maculopapular rash, fever, cough, coryza, conjunctivitis, koplik spots | Supportive | Either alone or as part of a combination (e.g., MMR, MMRV) | Iraq, South Sudan, Syria, Yemen |
Cholerac | Vibrio cholerae bacteria | Fecal–oral through contaminated food and water | Profuse watery diarrhea (“rice-water” diarrhea), symptoms of dehydration | Rehydration therapy, antibiotics for severe illness | Two oral killed vaccines: Dukoral and Shanchol (Shantha Biotechnics-Sanofi Pasteur) | South Sudan, Yemen |